These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 15548361)

  • 1. Selective loss of codon 72 proline p53 and frequent mutational inactivation of the retained arginine allele in colorectal cancer.
    Schneider-Stock R; Boltze C; Peters B; Szibor R; Landt O; Meyer F; Roessner A
    Neoplasia; 2004; 6(5):529-35. PubMed ID: 15548361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retention of the arginine allele in codon 72 of the p53 gene correlates with poor apoptosis in head and neck cancer.
    Schneider-Stock R; Mawrin C; Motsch C; Boltze C; Peters B; Hartig R; Buhtz P; Giers A; Rohrbeck A; Freigang B; Roessner A
    Am J Pathol; 2004 Apr; 164(4):1233-41. PubMed ID: 15039212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 mutation arising in Arg72 allele in the tumorigenesis and development of carcinoma of the urinary tract.
    Furihata M; Takeuchi T; Matsumoto M; Kurabayashi A; Ohtsuki Y; Terao N; Kuwahara M; Shuin T
    Clin Cancer Res; 2002 May; 8(5):1192-5. PubMed ID: 12006537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of the p53 codon 72 polymorphism on ovarian carcinogenesis and prognosis.
    Buller RE; Sood A; Fullenkamp C; Sorosky J; Powills K; Anderson B
    Cancer Gene Ther; 1997; 4(4):239-45. PubMed ID: 9253509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of p53 codon 72 polymorphism with advanced lung cancer: the Arg allele is preferentially retained in tumours arising in Arg/Pro germline heterozygotes.
    Papadakis ED; Soulitzis N; Spandidos DA
    Br J Cancer; 2002 Oct; 87(9):1013-8. PubMed ID: 12434294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of p53, K-ras and DCC gene alterations in the stage I-II colorectal cancers.
    Akkiprik M; Ataizi-Celikel C; Düşünceli F; Sönmez O; Gulluoglu BM; Sav A; Ozer A
    J Gastrointestin Liver Dis; 2007 Mar; 16(1):11-7. PubMed ID: 17410283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of evidence that proline homozygosity at codon 72 of p53 and rare arginine allele at codon 31 of p21, jointly mediate cervical cancer susceptibility among Indian women.
    Bhattacharya P; Sengupta S
    Gynecol Oncol; 2005 Oct; 99(1):176-82. PubMed ID: 16054204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arginine and proline alleles of the p53 gene are associated with different locations of gastric cancer.
    Lai KC; Chen WC; Tsai FJ; Li SY; Jeng LB
    Hepatogastroenterology; 2005; 52(63):944-8. PubMed ID: 15966238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of p53 mutations in colorectal liver metastases and correlation with clinical parameters.
    Tullo A; D'Erchia AM; Honda K; Mitry RR; Kelly MD; Habib NA; Saccone C; Sbisà E
    Clin Cancer Res; 1999 Nov; 5(11):3523-8. PubMed ID: 10589767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of combined allelic imbalance and mutations of p53 in tumor progression and survival following surgery for colorectal carcinoma.
    Lagerstedt KK; Kressner U; Lönnroth C; Nordgren S; Lundholm K
    Int J Oncol; 2005 Dec; 27(6):1707-15. PubMed ID: 16273227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preferential retention of codon 72 arginine p53 in squamous cell carcinomas of the vulva occurs in cancers positive and negative for human papillomavirus.
    Brooks LA; Tidy JA; Gusterson B; Hiller L; O'Nions J; Gasco M; Marin MC; Farrell PJ; Kaelin WG; Crook T
    Cancer Res; 2000 Dec; 60(24):6875-7. PubMed ID: 11156383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The p53 codon 72 proline allele is associated with p53 gene mutations in non-small cell lung cancer.
    Hu Y; McDermott MP; Ahrendt SA
    Clin Cancer Res; 2005 Apr; 11(7):2502-9. PubMed ID: 15814626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P53 mutations in colorectal cancer assessed in both genomic DNA and cDNA as compared to the presence of p53 LOH.
    Forslund A; Kressner U; Lönnroth C; Andersson M; Lindmark G; Lundholm K
    Int J Oncol; 2002 Aug; 21(2):409-15. PubMed ID: 12118339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TP53 mutation, allelism and survival in non-small cell lung cancer.
    Nelson HH; Wilkojmen M; Marsit CJ; Kelsey KT
    Carcinogenesis; 2005 Oct; 26(10):1770-3. PubMed ID: 15905205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P53 mutations in colorectal cancer from northern Iran: Relationships with site of tumor origin, microsatellite instability and K-ras mutations.
    Mahdavinia M; Bishehsari F; Verginelli F; Cumashi A; Lattanzio R; Sotoudeh M; Ansari R; Semeraro D; Hormazdi M; Fakheri H; Rakhshani N; De Lellis L; Curia MC; Cama A; Piantelli M; Malekzadeh R; Iacobelli S; Mariani-Costantini R
    J Cell Physiol; 2008 Aug; 216(2):543-50. PubMed ID: 18330889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotyping of p53 codon 175 in colorectal cancer.
    Krajewska WM; Stawińska M; Bryś M; Młynarski W; Witas HW; Okruszek A; Kiliańska ZM
    Med Sci Monit; 2003 May; 9(5):BR188-91. PubMed ID: 12761448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of genetic mutations of tumor suppresser genes in colorectal cancer patients.
    Kubo H; Miki C; Kusunoki M
    Hepatogastroenterology; 2004; 51(55):114-7. PubMed ID: 15011843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in the p53 and Ki-ras genes, microsatellite instability and site of tumor origin in colorectal cancer.
    Catalano T; Curia MC; Aceto G; Verginelli F; Cascinu S; Cama A; Mariani-Costantini R; Teti D; Battista P
    Oncol Rep; 2005 Sep; 14(3):625-31. PubMed ID: 16077965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective assessment of allelic losses at 4p14-16 in colorectal cancer: two mutational patterns and a locus associated with poorer survival.
    Arribas R; Ribas M; Risques RA; Masramon L; Tórtola S; Marcuello E; Aiza G; Miró R; Capellà G; Peinado MA
    Clin Cancer Res; 1999 Nov; 5(11):3454-9. PubMed ID: 10589758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The TP53 codon 72 polymorphism may affect the function of TP53 mutations in breast carcinomas but not in colorectal carcinomas.
    Langerød A; Bukholm IR; Bregård A; Lønning PE; Andersen TI; Rognum TO; Meling GI; Lothe RA; Børresen-Dale AL
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1684-8. PubMed ID: 12496062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.